Hakan Sevinç

Dr. Hakan Sevinç

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 March 2024 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
PDF file
ÇEÇağrı Ergin
Çağrı Ergin
ÖZGÜR KURTÖZGÜR KURT
ÖZGÜR KURT
MTMurat Türkoğlu
Murat Türkoğlu
HSHakan Sevinç
Hakan Sevinç
GAGöknur Akbaba
Göknur Akbaba
Objectives: Malassezia species are common, clinically relevant, and lipid‐dependent yeasts of humans. They are also the leading causes of the dandruff problem of humans, and the azoles are used primarily in their topical and systemic treatment. Resistance to azoles is an emerging problem among Malassezia sp., which indicates the need of new drug assessments that will be effective against dandruff and limit the use of azoles and other agents in treatment. Among them, the efficacy of various combinations of piroctone olamine and climbazole against Malassezia sp. is highly important. Here, we assessed the efficacies of various piroctone olamine and climbazole formulations against Malassezia sp. in comparison with ketoconazole.Methods: A total of nine formulations were included in the study, where each formulation was prepared from different concentrations of piroctone olamine and climbazole and both. All formulations contained the same ingredients as water, surfactants, hair conditioning agents, and preservatives. Malassezia furfur CBS1878, Malassezia globosa CBS7874, and Malassezia sympodialis CBS9570 were tested for antifungal susceptibility of each formulation by agar diffusion method. Sizes of the inhibition zones were compared with standard medical shampoo containing 2% ketoconazole, and the data were analyzed by Dunnett's multiple‐comparison test.Results: For all Malassezia sp. strains, climbazole 0.5% and piroctone olamine/climbazole (0.1%/0.1% and 0.1%/0.5%) combinations were found to have the same effect as the medical shampoo containing 2% ketoconazole. Piroctone olamine/climbazole 1.0%/0.1% formulation showed the same efficacy as 2% ketoconazole on M. furfur and M. sympodialis, while 0.1%/0.5% formulation to only M. furfur. For M. globosa, none of the formulations tested were as effective as ketoconazole.Conclusion: The species distribution of Malassezia sp. varies depending on the anatomical location on the host. According to the results of this study, climbazole and piroctone olamine combinations seem to be promising options against the dandruff problem with their high antifungal/anti dandruff efficacy.

21 February 2026 in Molecules
Verified
Journal Article
Open access
PDF file
YUYasemin Yagan Uzuner
Yasemin Yagan Uzuner
HSHakan Sevinç
Hakan Sevinç
ZKZeynep Kanlidere
Zeynep Kanlidere
Background: Hydrolyzed collagen peptides (HCP) are widely used as bioactive ingredients in anti-aging and skin rejuvenation formulations due to their role in supporting skin hydration, elasticity, and extracellular matrix integrity. However, their high hydrophilicity limits effective incorporation into lipid-based systems, and restricts controlled release from formulations. Objective: In this study, ethosomal nanocarriers were designed as a phospholipid–ethanol-based system to promote favorable molecular interactions with hydrophilic peptides, aiming to enhance the encapsulation, stability, and controlled release of HCP for dermocosmetic applications. Methods: HCP-loaded ethosomes were prepared using phospholipid (Lipoid P75) and ethanol and optimized by varying high-pressure homogenization cycles. Physicochemical properties, including vesicle size, distribution uniformity, zeta potential, pH, and long-term stability, were monitored for up to 180 days. Vesicle morphology and peptide–lipid interactions were characterized using cryo-scanning electron microscopy and FTIR spectroscopy. Encapsulation efficiency was determined by ultrafiltration, while cytocompatibility was assessed in HaCaT keratinocyte cells. In vitro release behavior was investigated using Franz diffusion cells and compared with aqueous HCP solutions. Results: All formulations exhibited nanoscale size distribution and high colloidal stability, with negative zeta potentials ranging from −42.9 to −76.7 mV. The optimized formulation demonstrated sustained encapsulation efficiency (73% after 180 days) and preservation of peptide structure, as confirmed by FTIR, indicating effective chemical stabilization within the ethosomal matrix. Cytotoxicity studies confirmed good skin cell compatibility. In vitro release studies revealed a controlled and prolonged release profile from ethosomal carriers compared with free HCP solutions, suggesting improved topical bioavailability of collagen peptides. Conclusions: To the best of our knowledge, this work provides one of the first systematic investigations of optimized ethosomal systems for the stabilization of hydrophilic collagen peptides as anti-aging dermocosmetic ingredients. These findings demonstrate that optimized HCP-loaded ethosomes represent a promising ingredient formulation platform enabling bioactive preservation, formulation stability, and controlled topical performance for collagen-based skin rejuvenation applications.

29 September 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YUYasemin Yagan Uzuner
Yasemin Yagan Uzuner
HSHakan Sevinç
Hakan Sevinç
Background: Trans-resveratrol (3,5,4′-trihydroxystilbene) is a natural polyphenolic antioxidant widely used in anti-aging dermocosmetics for its strong radical-scavenging capacity and its activation of cell-protective pathways such as sirtuin 1 (SIRT1). However, its poor aqueous solubility, photochemical lability, and low bioavailability limit its incorporation into topical formulations and its delivery into the skin. Objective: In this study, ethosomal nanocarriers were designed as a phospholipid–ethanol vesicular system to solubilize, stabilize, and control the release of trans-resveratrol for dermocosmetic applications. Microfluidization is not a commonly used method; however, circulating the formulation through the interaction chamber under optimized pressure can produce ethosomes with desirable colloidal stability by this simple process. Methods: Resveratrol-loaded ethosomes were prepared with synthetic phosphatidylcholine (Lipoid P75), ethanol, and vitamin E. Microfluidization was optimized by varying the number of high-pressure homogenization cycles and the applied pressure. Vesicle size, size distribution and distribution uniformity, zeta potential, pH, conductivity, density, and long-term stability were monitored for up to 180 days; morphology was examined by cryogenic scanning electron microscopy (cryo-SEM) and molecular compatibility by Fourier-transform infrared (FTIR) spectroscopy. A trans-resveratrol high-performance liquid chromatography (HPLC) assay was developed and validated according to International Council for Harmonisation (ICH) Q2 guidelines for quantitative analysis. Encapsulation efficiency was determined by HPLC after ultracentrifugation, cytotoxicity was assessed in human keratinocytes (HaCaT), and in vitro release was evaluated using Franz diffusion cells with two different membranes. Results: All ethosome formulations yielded a nanoscale size distribution (median diameter around 190 nm for loaded and around 90 nm for unloaded) and good colloidal stability, with absolute zeta potentials above the 30 mV threshold at early time points and a skin-compatible pH (around 6.5). The optimized formulation (T16; 1.5% w/w trans-resveratrol, 5% w/w phosphatidylcholine (Lipoid P75), 0.3% w/w vitamin E and 30% w/w ethanol, processed with seven microfluidization cycles) achieved a high encapsulation efficiency (EE) of 95.5% on day 1. 84.2% EE was retained after 180 days, consistent with strong partitioning of the lipophilic active into the ethanol–phospholipid bilayer. FTIR confirmed preservation of the phospholipid bilayer and indicated non-covalent loading, with the resveratrol bands largely masked by the dominant lipid signals. Cryogenic Scanning Electron Microscopy (Cryo-SEM) confirmed near-spherical vesicles with narrow size distribution. In vitro release showed a sustained, controlled release profile relative to a 1.5% w/w resveratrol solution. Slower diffusion across the skin-mimicking Strat-M membrane was observed compared to cellulose acetate membrane. Conclusions: Optimized trans-resveratrol-loaded ethosomes represent a stable, efficient vesicular system enabling formulation stability and controlled topical release. The antioxidant and photoprotective efficacy of the loaded system was not assessed in this study and is identified as a topic for future work.

Verified
Journal Article
Open access
PDF file
GÖGülistan Öncü
Gülistan Öncü
MTMurat Türkoğlu
Murat Türkoğlu
ATALI TURKAN
ALI TURKAN
HSHakan Sevinç
Hakan Sevinç
Current treatment options for hair loss remain limited. Therefore, this study compared a botanical extract derived from multiple plants with the pharmaceutical agent minoxidil for topical application. The evaluated parameters included inflammatory cytokines (IL-1β, IL-6, TNF-α), growth factors (TGF-β, VEGF, KGF), and 5α-reductase type II (SRD5A2) expression in the human keratinocyte cell line HaCaT, as measured by ELISA. Both the botanical extract and minoxidil reduced IL-6 levels by 21% and 35%, and TNF-α levels by 13% and 35%, respectively. Treatment with the botanical extract and minoxidil increased VEGF expression by 50% and 85%, and KGF by 16% and 31%, respectively, while reducing SRD5A2 expression by 21% and 28%, respectively. Overall, the results of this in vitro study suggest that the botanical extract exhibits a response pattern similar to that of minoxidil, characterized by the suppression of pro-inflammatory cytokines and SRD5A2, along with enhanced expression of growth factors VEGF and KGF in HaCaT cells. These results provide a promising basis for further in vivo studies.

20 October 2026 in Biomolecules
Verified
Journal Article
Open access
PDF file
MTMurat Türkoğlu
Murat Türkoğlu
ATALI TURKAN
ALI TURKAN
GÖGülistan Öncü
Gülistan Öncü
HSHakan Sevinç
Hakan Sevinç
EPErkin Pekmezci
Erkin Pekmezci
Retinol, a vitamin A derivative belonging to the retinoid family, is widely recognized for its anti-aging and wound-healing properties. In this study, we investigated the effects of retinol on the production of growth factors and major extracellular matrix (ECM) components in human dermal fibroblasts. Cells were treated with 0.05 and 0.5 μM retinol, and the levels of vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF-2), transforming growth factor-beta (TGF-β), hyaluronan synthase-2 (HAS-2), collagen type-I (COL-I), and collagen type-III (COL-III) were quantified using ELISA. Retinol treatment significantly increased the levels of VEGF, FGF-2 and TGF-β at both concentrations tested. Similarly, the levels of the ECM-related markers HAS-2, COL-I and COL-III were elevated following retinol exposure at both concentrations. Collectively, these findings indicate that retinol induces a coordinated pro-regenerative response in human dermal fibroblasts, characterized by enhanced extracellular matrix production, angiogenic signaling, hyaluronic acid synthesis, and tissue remodeling. These results further support the role of retinol as an antiaging and wound healing agent that promotes skin regeneration and maintenance.

28 August 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
YUYasemin Yagan Uzuner
Yasemin Yagan Uzuner
HSHakan Sevinç
Hakan Sevinç
Background: Trans-resveratrol (3,5,4′-trihydroxystilbene) is a natural polyphenolic antioxidant widely used in anti-aging dermocosmetics for its strong radical-scavenging capacity and its activation of cell-protective pathways such as SIRT1. However, its poor aqueous solubility, photochemical lability, and low bioavailability limit its incorporation into topical formulations and its delivery into the skin. Objective: In this study, ethosomal nanocarriers were designed as a phospholipid–ethanol vesicular system to solubilize, stabilize, and control the release of trans-resveratrol for dermocosmetic applications. Microfluidization process is not a commonly used method, however under optimized pressure circulating the formulation through the interaction chamber can produce ethosomes with desirable colloidal stability as an easy method. Methods: Resveratrol-loaded ethosomes were prepared with synthetic phosphatidylcholine (Lipoid P75), ethanol, and vitamin E. Microfluidisation was used as an easy method which was optimized by varying the number of high-pressure homogenization cycles and the pressure applied. Vesicle size, size distribution and distribution uniformity, zeta potential, pH, conductivity, density, and long-term stability were monitored for up to 180 days; morphology was examined by cryo-SEM and molecular compatibility by FTIR. A trans-resveratrol HPLC assay was developed and validated according to ICH Q2guidelines for quantitative analysis. Encapsulation efficiency was determined by HPLC after ultracentrifugation, cytotoxicity was assessed in HaCaT keratinocytes, and in vitro release was evaluated using Franz diffusion cells with two different membranes. Results: All ethosome formulations yielded a nanoscale size distribution (median diameter around 190 nm) and good colloidal stability, with absolute zeta potentials above the 30 mV threshold at early time points and had skin-compatible pH (around 6.5). The optimized formulation (T16) achieved a high encapsulation efficiency (EE) of 95.5% on day 1, 84.2% EE was retained after 180 days, consistent with strong partitioning of the lipophilic active into the ethanol–phospholipid bilayer. FTIR confirmed preservation of the phospholipid bilayer and indicated non-covalent loading, with the resveratrol bands largely masked by the dominant lipid signals. Cryo-SEM confirmed near-spherical vesicles with narrow size distribution. In vitro release showed a sustained, controlled release profile relative to a 1.5% resveratrol solution. Slower diffusion across the skin-mimicking Strat-M membrane was observed compared to cellulose acetate membrane. Conclusions: Using Optimized trans-resveratrol-loaded ethosomes represent a stable, efficient ethosomes enabling formulation stability and controlled topical release. The antioxidant and photoprotective efficacy of the loaded system was not assessed in this study and is identified as a topic for future work.